⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 1, 1994Journal of Clinical Oncology

Attainment of molecular remission: a worthwhile goal?

John G. Gribben

View at Publisher

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Article Tools Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.1994.12.8.1532 Journal of Clinical Oncology - published online before print September 21, 2016 PMID: 8040663 Attainment of molecular remission: a worthwhile goal? J G GribbenxJ G GribbenSearch for articles by this author https://doi.org/10.1200/JCO.1994.12.8.1532 First Page PDF © 1994 by American Society of Clinical Oncology

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

John G. Gribben (1994) studied this question.

synapsesocial.com/papers/6a7138e6af0c21e93928da8e https://doi.org/10.1200/jco.1994.12.8.1532

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Per- and Polyfluoroalkyl Substance Exposure and Breast Cancer Incidence in the Sister StudyJournal of Clinical Oncology · 2026
2International Initiative on a Refined Staging System for Medullary Thyroid Cancer: A Multinational Multicenter StudyJournal of Clinical Oncology · 2026
3Circulating Tumor DNA Profiling Across Phase II/III Ewing Sarcoma Trials Identifies High-Risk Patients With TP53 , STAG2 , and CDKN2A AlterationsJournal of Clinical Oncology · 2026
4Feasibility and Tolerability of Chemoimmunotherapy Given During Induction for Treatment of Patients With High-Risk Neuroblastoma: A Report From the Children's Oncology GroupJournal of Clinical Oncology · 2026
5Stereotactic Ablative Radiotherapy Versus Surgical Resection for Early-Stage Non–Small Lung Cancer: An Emulated Target TrialJournal of Clinical Oncology · 2026
6Immunochemotherapy for Borderline Resectable or Locally Advanced Pancreatic Cancer: A Randomized Controlled TrialJournal of Clinical Oncology · 2026
7Methylphenidate for Hematologic Cancer–Related Fatigue: A Randomized Clinical TrialJournal of Clinical Oncology · 2026
8Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.4Journal of Clinical Oncology · 2026
9KEYNOTE-867: A Phase III, Randomized, Double-Blind Study of Stereotactic Body Radiotherapy With Pembrolizumab for Unresected Stage I or II Non–Small Cell Lung CancerJournal of Clinical Oncology · 2026
10Darovasertib and Crizotinib First-Line Treatment for Metastatic Uveal Melanoma: Overall Survival, Efficacy, and Safety From the OptimUM-01 StudyJournal of Clinical Oncology · 2026

More from Journal of Clinical Oncology